Significant increase in prostaglandin E-main urinary metabolite by laxative administration: Comparison with ulcerative colitis

Digestion

Volumn 61, Issue 3, 2000, Pages 201-206

  Fujiwara, Mutsunori ^a   Okayasu, Isao ^b   Oritsu, Masae ^a   Komatsu, Junko ^a   Yoshitsugu, Michiyasu ^a   Katoh, Yoshihisa ^a   Bandoh, Takafumi ^a   Toyoshima, Hiroshi ^a   Kase, Yoshio ^c   Sugihara, Kunio ^d   Kanno, Jun ^e   Hayashi, Yuzo ^f  

^a JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TSUMURA AND CO   (Japan)

^d Kudanzaka Hospital   (Japan)

^e NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^f KITASATO UNIVERSITY   (Japan)

Author keywords

Laxatives; Prostaglandin E; Ulcerative colitis

Indexed keywords

PROSTAGLANDIN E2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MALE; METABOLITE; PRIORITY JOURNAL; ULCERATIVE COLITIS; URINE;

EID: 0034038936     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007758     Document Type: Article

References (20)

1. Goodwin JS, Ceuppens J: Regulation of the immune response by prostaglandins. J Clin Immunol 1983;3:295-315.
2. Inagawa T, Imaki K, Masuda H, Morikawa Y, Hirata F, Tsuboshima M: Simplified immunoassays of prostaglandin E main metabolite in human urine. Adv Prostaglandin Thromboxane Leukot Res 1983;11:191-196.
3. Hamberg M, Samuelsson B: On the metabolism of prostaglandins E1 and E2 in man. J Biol Chem 1971;246:6713-6721.
4. Yamada K, Aizawa Y: Effects of anti-inflammatory drugs on urinary excretion of prostaglandin metabolites in cotton pellet inflammation. Eur J Pharmacol 1983;90:91-95.
5. Driman DK, Preiksaitis HG: Colorectal inflammation and increased cell proliferation associated with oral sodium phosphate bowel preparation solution. Hum Pathol 1988;29: 972-978.
6. Morson BC, Dawson IMP: Gastrointestinal Pathology, ed 4. Oxford, Blackwell Scientific, 1991, pp 491-514.
7. Talstad I, Gjone E: The disease activity of ulcerative colitis and Crohn's disease. Scand J Gastroenterol 1976;11:403-408.
8. Wardle TD, Turnberg LA: Potential role for interleukin-1 in the pathophysiology of ulceralive colitis. Clin Sci 1994;86:619-626.
9. Motley RJ, Rhodes J, Williams G, Tavares IA, Bennett A: Smoking, eicosanoids and ulcerative colitis. J Pharm Pharmacol 1990;42:288-289.
10. Nygard G, Larsson A, Gerdin B, Ejerblad S, Berglindh T: Viability, prostaglandin E2 production, and protein handling in normal and inflamed human colonic mucosa cultured for up to 48 h in vitro. Scand J Gastroenterol 1992; 27:303-310.
11. Wardle TD, Hall L, Turnberg LA: Inter-relationships between inflammatory mediators released from colonic mucosa in ulcerative colitis and their effects on colonic secretion. Gut 1993;34:503-508.
12. Phillips TE, Stanley CM, Wilson J: The effect of 16,16-dimethyl prostaglandin E2 on proliferation of an intestinal goblet cell line and its synthesis and secretion of mucin glycoproteins. Prostaglandins Leukot Essent Fatty Acids 1993;48:423-428.
13. Gertner DJ, Rampton DS, Madden MV, Talbot IC, Nicholls RJ, Lennard-Jones JE: Increased leukotriene B4 release from ileal pouch mucosa in ulcerative colitis compared with familial adenomalous polyposis. Gut 1994;35: 1429-1432.
14. Casellas F, Papo M, Guarner F, Antolin M, Armengol JR, Malagelada JR: Intraluminal colonic release of immunoreactive tumour necrosis factor in chronic ulcerative colitis. Clin Sci 1994;87:453-458.
15. Raab Y, Sundberg C, Hallgren R, Knutson L, Gerdin B: Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis. Am J Gastroenterol 1995;90:614-620.
16. Yamashita S: Studies on changes of colonic mucosal PGE2 levels and tissue localization in experimental colitis. Gastroenterol Jpn 1993; 28:224-235.
17. Nishikawa A, Kase Y, Hayakawa T, Yanagisawa T, Kanno J, Hayashi Y: Enhancement of cell proliferation and prostaglandin biosynthesis by 1.8-dihydroxyanthraquinone in the rat large intestine. Carcinogenesis 1997;18:1259-1263.
18. Sasaki K, Yamauchi K, Kuwano S: Metabolic activation of sennoside A in mice. J Med Plant Res 1979;37:370-378.
19. Lemli J, Lemmens L: Metabolism of sennosides and rhein in the rat. Pharmacology 1980; 20(suppl):50-57.
20. Piegsa-Quischotte I: Klinische Erfahrungen bei der Behandlung hartnäckiger Obstipationen mit einem Sennaglukosid. Äretl Wochenschr 1954;9:499-502.